TOFACITINIB
NDC 72162-2684, TOFACITINIB, tablet, extended release, from Bryant Ranch Prepack.
- Product NDC
- 72162-2684
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218462
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2684 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72162-2684-3 | 72162268403 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2684-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/89211a4d-befb-40f1-8792-aa599fdd794c
Use it
Look up 72162-2684 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2684 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72162-2684. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.